Table 1 The baseline characters of the studied groups
From: Impact of COVID-19 on endoscopic follow-up of gastroesophageal varices
Group A (112) | Group B (126) | |
|---|---|---|
Age (range in years) | 46 (17–71) | 48 (21–66) |
Female/male | 44/68 | 52/74 |
Hematemesis | 16 (14%) | 28 (22%) |
Melena | 18 (16%) | 22 (18%) |
Both | 78 (70%) | 76 (60%) |
Child class (number & %) | ||
A | 21 (19%) | 26 (21%) |
B | 66 (59%) | 78 (62%) |
C | 25 (22%) | 22 (17%) |
Hemodynamic instability number & % | 51 (49%) | 62 (55%) |
Median MELD score | 12 (7–34) | 11 (8–33) |
INR | 1.5 (1.1–2.4) | 1.6 (1.2–2.6) |
Bilirubin (mg/dl) | 1.3 (0.9–14) | 1.5 (1–21) |
Albumin (g/dl) | 3.2 (2.4–4.1) | 3 (2.2–4.5) |
Creatinine (mg/dl) | 1 (0.9–2.8) | 0.9 (0.8–6.2) |
ALT | 48 (26–212) | 44 (18–466) |
AST | 52 (22–288) | 49 (16–512) |
Median number of varices | 4 (1–6) | 4 (1–6) |
Size of varices | ||
Small | 34 (31%) | 42 (34%) |
Large | 78 (69%) | 84 (66%) |